PFC
VIVO

Phocas Financial Corp’s Meridian Bioscience Inc VIVO Stock Holding History

Phocas Financial Corp’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-134,740
Closed -$3.54M – 225
2021
Q1 		$3.54M Sell
134,740
-43,424
-24% -$1.03M 0.47% 94
2020
Q4 		$3.33M Sell
178,164
-36,218
-17% -$676K 0.51% 84
2020
Q3 		$3.64M Buy
214,382
+6,860
+3% +$133K 0.63% 68
2020
Q2 		$4.83M Buy
+207,522
New +$3.01M 0.86% 45

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Phocas Financial Corp's VIVO Position: Q2 2021 in Review

Phocas Financial Corp sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 134,740 shares — an estimated $3.54M sold.

Phocas Financial Corp first reported a position in VIVO in Q2 2020 and held it in 4 quarters. The position peaked at $4.83M in Q2 2020. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • Phocas Financial Corp reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
  • Phocas Financial Corp sold 134,740 Meridian Bioscience Inc shares in Q2 2021, an estimated $3.54M.
  • Phocas Financial Corp first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 4 quarters.
  • Phocas Financial Corp's Meridian Bioscience Inc position peaked at $4.83M in Q2 2020.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Phocas Financial Corp's 13F filing for Q2 2021, filed 16 Aug 2021.